GSK recalls two lamotrigine batches
The issue, which affects only two batches of the anticonvulsant, is "unlikely" to affect plasma concentrations, but there is a "very low" risk of reduced efficacy, the manufacturer has advised.
The affected stock is as follows:
Lamictal (lamotrigine) 200mg tablets
Batch nos: PJ1925 and PJ1926
Expiry dates: 31 August, 2013
Pharmacists should quarantine affected stock and return it through their wholesaler.
Please note You must be a registered user of Chemist+Druggist and logged in to add comments. Opinions expressed here are those of the writers and do not necessarily reflect those of Chemist+Druggist. Comments are considered in the public domain and may be used in future Chemist+Druggist coverage. We accept no responsibility, legal or otherwise, for the accuracy or the content of member comments.
